Европска Унија -
Норвешки -
EMA (European Medicines Agency)
natpar
takeda pharmaceuticals international ag ireland branch - parathyroidhormon - hypoparathyroidisme - kalsiumhomeostase - natpar er indisert som tilleggsbehandling av voksne pasienter med kronisk hypoparathyroidisme som ikke kan kontrolleres tilstrekkelig med standard terapi alene.
Норвешка -
Норвешки -
Statens legemiddelverk
symbicort 160 mikrog/ dose / 4.5 mikrog/ dose
astrazeneca - budesonid / formoterolfumaratdihydrat - inhalasjonsaerosol, suspensjon - 160 mikrog/ dose / 4.5 mikrog/ dose
Европска Унија -
Норвешки -
EMA (European Medicines Agency)
takhzyro
takeda pharmaceuticals international ag ireland branch - lanadelumab - angioødemer, arvelig - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.
Норвешка -
Норвешки -
Statens legemiddelverk
cymbalta 30 mg
2care4 aps - duloksetinhydroklorid - enterokapsel, hard - 30 mg
Норвешка -
Норвешки -
Statens legemiddelverk
cymbalta 60 mg
2care4 aps - duloksetinhydroklorid - enterokapsel, hard - 60 mg
Европска Унија -
Норвешки -
EMA (European Medicines Agency)
vyepti
h. lundbeck a/s - eptinezumab - migrene lidelser - analgetika - vyepti is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.
Европска Унија -
Норвешки -
EMA (European Medicines Agency)
lyfnua
merck sharp & dohme b.v. - gefapixant - cough - hoste og kalde preparater - lyfnua is indicated in adults for the treatment of refractory or unexplained chronic cough.
Европска Унија -
Норвешки -
EMA (European Medicines Agency)
orfadin
swedish orphan biovitrum international ab - nitisinone - tyrosinemias - andre alimentary tract and metabolism products, - hereditary tyrosinemia type 1 (ht 1)orfadin is indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht 1) in combination with dietary restriction of tyrosine and phenylalanine. alkaptonuria (aku)orfadin is indicated for the treatment of adult patients with alkaptonuria (aku).
Европска Унија -
Норвешки -
EMA (European Medicines Agency)
nityr
cycle pharmaceuticals (europe) ltd - nitisinone - tyrosinemias - andre alimentary tract and metabolism products, - behandling av voksne og paediatric pasienter med bekreftet diagnosen arvelig tyrosinemia type 1 (ht-1) i kombinasjon med kosttilskudd begrensning av tyrosin og fenylalanin.
Норвешка -
Норвешки -
Statens legemiddelverk
nitisinone dipharma 5 mg
dipharma arzneimittel gmbh - nitisinon - kapsel, hard - 5 mg